Pharmaceutical Technology16 小时
Amelenodor by AbbVie for Crohn’s Disease (Regional Enteritis): Likelihood of Approval
Amelenodor is under clinical development by AbbVie and currently in Phase I for Crohn's Disease (Regional Enteritis).
Inside home of Emmerdale star Jeff Hordley including adaption for chronic condition
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...
Struggling In The Bedroom? Your Gut Health May Be To Blame For Erectile Dysfunction
A recent research reveals a surprising link between erectile dysfunction (ED) and irritable bowel syndrome (IBS). Men ...
Pharmaceutical Technology7 小时
SHRA-1921 by Jiangsu Hengrui Medicine for Metastatic Breast Cancer: Likelihood of Approval
SHRA-1921 is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for Metastatic Breast Cancer.
Connect Biopharma (NASDAQ:CNTB) vs. Janone (NASDAQ:ALTS) Head-To-Head Review
Connect Biopharma (NASDAQ:CNTB – Get Free Report) and Janone (NASDAQ:ALTS – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two ...
腾讯网19 小时
年度盘点丨马雄教授：自身免疫性肝病2024年研究进展
诊断方面，2022年国际AIH小组发表的新共识将汇管区炎症和小叶内炎症均作为AIH的病理特征，强调了病理组织学在AIH诊断中不可或缺的地位。2024年一项回顾性研究提出，相较于应用广泛的2008年简化标准中的AIH病理评分，2022年IAHPG病理评分可能具有更高的诊断敏感性，特别是对于急性起病的AIH [1]。